...
首页> 外文期刊>Pediatric Nephrology >Membranous lupus nephritis in Chinese children—a case series and review of the literature
【24h】

Membranous lupus nephritis in Chinese children—a case series and review of the literature

机译:中国儿童膜性狼疮性肾炎一例病例并文献复习

获取原文
获取原文并翻译 | 示例
           

摘要

We retrospectively reviewed the cases of 13 lupus nephritis children with pure membranous glomerulonephritis (MGN; Group A) and ten children with mixed proliferative and membranous nephritis (Group B). The children were identified through a territory-wide survey of patients between 1990 and 2003. All were ethnic Chinese. Age at diagnosis ranged from 3.7 to 18.6 years (Group A) and from 9.6 to 22.1 years (Group B). Female-to-male ratios were 12:1 (Group A) and 9:1 (Group B). Group A patients were more often nephrotic than Group B patients (11/13 vs. 5/10, p = 0.17). The glomerular filtration rate (GFR) at presentation was normal in all but two patients (one from each group). For induction, Group B patients consistently received prednisolone and cyclophosphamide; in contrast, the cytotoxic regimens in Group A patients varied from cyclophosphamide (five patients), mycophenolate mofetil (two patients), azathiorpine plus cyclosporine (one patient), and azathioprine alone (one patient). After a median follow-up of 7.6–7.8 years, one Group A patient had died of fulminant lupus. One survivor in Group B had a GFR < 90 ml/min per 1.73 m2. Proteinuria persisted in five Group A patients and two Group B patients. In conclusion, Group B patients had good prognosis in terms of survival and proteinuria control. The only death occurred in Group A, and five of the 12 survivors in this group had persistent proteinuria. Further studies are needed to define the best treatment for pure lupus MGN.
机译:我们回顾性分析了13例纯膜性肾小球肾炎患儿(MGN; A组)和10例混合性增生性和膜性肾炎患儿(B群)的病例。这些儿童是通过1990年至2003年对患者进行的全美调查确定的。所有儿童均为华裔。诊断时年龄为3.7至18.6岁(A组)和9.6至22.1岁(B组)。男女比例为12:1(A组)和9:1(B组)。 A组患者比B组患者更常见肾病(11/13 vs. 5/10,p = 0.17)。除两名患者外,其他所有患者(每组一名)的肾小球滤过率(GFR)均正常。为了诱导,B组患者始终接受泼尼松龙和环磷酰胺治疗;相比之下,A组患者的细胞毒性治疗方案包括环磷酰胺(5例),霉酚酸酯(2例),硫唑嘌呤加环孢素(1例)和仅硫唑嘌呤(1例)。在中位随访7.6-7.8年后,A组患者死于暴发性狼疮。 B组中一名幸存者的GFR <1.7 ml / min / 1.73 m 2 。 5名A组患者和2名B组患者持续存在蛋白尿。总之,就生存率和蛋白尿控制而言,B组患者预后良好。唯一的死亡发生在A组,该组的12名幸存者中有5名患有持续性蛋白尿。需要进一步的研究来确定纯狼疮MGN的最佳治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号